Nityr™ (nitisinone) – New drug approval
July 26, 2017 – The FDA announced the approval of Cycle Pharmaceuticals’ Nityr (nitisinone) tablets, for the treatment of hereditary tyrosinemia type 1 (HT-1) in combination with dietary restriction of tyrosine and phenylalanine.
Download PDF
